Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) EPS (Basic): 2021-2025

Historic EPS (Basic) for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$0.00.

  • Immunocore Holdings' EPS (Basic) fell 102.29% to -$0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.57, marking a year-over-year increase of 39.59%. This contributed to the annual value of -$1.02 for FY2024, which is 9.73% up from last year.
  • Latest data reveals that Immunocore Holdings reported EPS (Basic) of -$0.00 as of Q3 2025, which was up 98.06% from -$0.20 recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' EPS (Basic) registered a high of $0.17 during Q3 2024, and its lowest value of -$1.20 during Q4 2021.
  • Its 3-year average for EPS (Basic) is -$0.20, with a median of -$0.23 in 2024.
  • In the last 5 years, Immunocore Holdings' EPS (Basic) soared by 750.00% in 2024 and then slumped by 102.29% in 2025.
  • Over the past 4 years, Immunocore Holdings' EPS (Basic) (Quarterly) stood at -$1.20 in 2021, then reached -$0.40 in 2023, then fell by 17.50% to -$0.47 in 2024, then slumped by 102.29% to -$0.00 in 2025.
  • Its EPS (Basic) was -$0.00 in Q3 2025, compared to -$0.20 in Q2 2025 and $0.10 in Q1 2025.